InfuSystem Holdings, Inc. (INFU) Stock Score, Valuation & Financial Research
InfuSystem Holdings, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 36/100.
Quick answer for INFU
InfuSystem Holdings, Inc. currently has a Wall Street Score of 36/100. The stored market price is $12.45. Its financial score is 36/100. Its valuation score is 16/100. These figures are a research snapshot, not a buy or sell recommendation.
What InfuSystem Holdings, Inc. does
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offe
INFU financial snapshot
- Wall Street Score:
- 36/100
- Current price:
- $12.45
- Market capitalization:
- $251.3M
- Revenue:
- $143.3M
- Net income:
- $8.5M
- Free cash flow:
- $15.7M
- Cash:
- $964K
- Total debt:
- $23.3M
- EPS:
- 0.42
- P/E ratio:
- 29.6x
- Financial score:
- 36/100
- Valuation score:
- 16/100
- Revenue score:
- 17/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $15.7M, showing positive cash generation.
- The balance sheet shows $964K of cash versus $23.3M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 36/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research INFU
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.